Search This Blog

Friday, December 13, 2019

Amarin shares halted pending news

Nasdaq has suspended trading in Amarin (AMRN +4.9%) pending the release of news. In this, probably the expected FDA nod for a CV benefit claim for Vascepa (icosapent ethyl). The agency’s action date is December 28.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)